LYEL logo

Lyell Immunopharma (LYEL) Cash From Investing

Annual CFI

$184.05 M
+$195.59 M+1694.87%

December 31, 2023


Summary


Performance

LYEL Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLYELcash flowmetrics:

Quarterly CFI

$1.92 M
-$43.09 M-95.74%

September 30, 2024


Summary


Performance

LYEL Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLYELcash flowmetrics:

TTM CFI

-$31.77 M
-$97.75 M-148.15%

September 30, 2024


Summary


Performance

LYEL TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLYELcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

LYEL Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1694.9%+101.9%-117.3%
3 y3 years+167.3%+102.6%+73.9%
5 y5 years+143.6%+104.9%-180.1%

LYEL Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+251.4%-98.8%+101.9%-109.6%+88.8%
5 y5-yearat high+143.6%-98.8%+101.3%-109.6%+89.6%
alltimeall timeat high+143.6%-98.8%+101.3%-109.6%+89.6%

Lyell Immunopharma Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.92 M(-95.7%)
-$31.77 M(-148.2%)
Jun 2024
-
$45.01 M(+104.6%)
$65.98 M(-62.1%)
Mar 2024
-
$21.99 M(-121.8%)
$173.89 M(-5.5%)
Dec 2023
$184.05 M(-1694.9%)
-$100.69 M(-201.0%)
$184.05 M(-44.5%)
Sep 2023
-
$99.67 M(-34.8%)
$331.39 M(+89.8%)
Jun 2023
-
$152.91 M(+375.6%)
$174.63 M(+273.6%)
Mar 2023
-
$32.15 M(-31.1%)
$46.74 M(-505.0%)
Dec 2022
-$11.54 M
$46.65 M(-181.7%)
-$11.54 M(-91.3%)
Sep 2022
-
-$57.09 M(-328.2%)
-$132.05 M(-39.9%)
Jun 2022
-
$25.02 M(-195.8%)
-$219.88 M(-22.7%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$26.12 M(-64.6%)
-$284.37 M(+133.9%)
Dec 2021
-$121.57 M(-55.6%)
-$73.86 M(-49.0%)
-$121.57 M(+693.4%)
Sep 2021
-
-$144.91 M(+267.1%)
-$15.32 M(-138.7%)
Jun 2021
-
-$39.47 M(-128.9%)
$39.65 M(-291.0%)
Mar 2021
-
$136.68 M(+322.0%)
-$20.76 M(-92.4%)
Dec 2020
-$273.52 M(-35.3%)
-
-
Dec 2020
-
$32.39 M(-136.0%)
-$273.52 M(-10.6%)
Sep 2020
-
-$89.94 M(-9.9%)
-$305.90 M(+41.6%)
Jun 2020
-
-$99.88 M(-14.0%)
-$215.96 M(+86.0%)
Mar 2020
-
-$116.08 M
-$116.08 M
Dec 2019
-$422.43 M
-
-

FAQ

  • What is Lyell Immunopharma annual cash flow from investing activities?
  • What is the all time high annual CFI for Lyell Immunopharma?
  • What is Lyell Immunopharma annual CFI year-on-year change?
  • What is Lyell Immunopharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Lyell Immunopharma?
  • What is Lyell Immunopharma quarterly CFI year-on-year change?
  • What is Lyell Immunopharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Lyell Immunopharma?
  • What is Lyell Immunopharma TTM CFI year-on-year change?

What is Lyell Immunopharma annual cash flow from investing activities?

The current annual CFI of LYEL is $184.05 M

What is the all time high annual CFI for Lyell Immunopharma?

Lyell Immunopharma all-time high annual cash flow from investing activities is $184.05 M

What is Lyell Immunopharma annual CFI year-on-year change?

Over the past year, LYEL annual cash flow from investing activities has changed by +$195.59 M (+1694.87%)

What is Lyell Immunopharma quarterly cash flow from investing activities?

The current quarterly CFI of LYEL is $1.92 M

What is the all time high quarterly CFI for Lyell Immunopharma?

Lyell Immunopharma all-time high quarterly cash flow from investing activities is $152.91 M

What is Lyell Immunopharma quarterly CFI year-on-year change?

Over the past year, LYEL quarterly cash flow from investing activities has changed by +$102.61 M (+101.90%)

What is Lyell Immunopharma TTM cash flow from investing activities?

The current TTM CFI of LYEL is -$31.77 M

What is the all time high TTM CFI for Lyell Immunopharma?

Lyell Immunopharma all-time high TTM cash flow from investing activities is $331.39 M

What is Lyell Immunopharma TTM CFI year-on-year change?

Over the past year, LYEL TTM cash flow from investing activities has changed by -$215.82 M (-117.26%)